Camolyn-brand eye drops are recalled

WASHINGTON, April 7 (UPI) -- The U.S. Food and Drug Administration announced the recall of over-the-counter Camolyn eye and Fisiolin nasal drops due to safety concerns.

The FDA said the US Oftalmi Corp. of Hallandale, Fla., initiated the voluntary recall because it cannot assure the sterility of the products, thereby giving them the potential of causing eye infections.

Eye drops being recalled are Camolyn-brand Homeopathic, Camolyn Plus, Camolyn Naphazoline and Chamomile Plus, Camolyn Refresh, Camolyn-A and Camolyn Naphazoline and Pheniramine.

Also being recalled are Fisiolin-brand nasal drops (sodium chloride) for pediatric use.

The products were distributed nationwide.

Consumers with questions can contact the company at 954-338-6891.